While global markets stumble from tariff wars, India's stock market leads the world in growth.
Driven by a bold “Made in India” vision, the country is set to challenge “Made in China” on the global manufacturing stage.
India’s partnership with the EU is reshaping life sciences, making it the new hub for CGT & advanced therapies.
CDMO market is projected to hit $26.73B by 2028 — the fastest growth worldwide at 14.7%.
India isn’t just rising — it’s redefining the future of global healthcare.
Learn more: https://bit.ly/v126cover
#IndiaBiotech #MadeInIndia #LifeSciences #CGT #CDMO #HealthcareInnovation #BiotechGrowth #MedTech #DigitalHealth #GlobalShift